Client
- Name
- REGENXBIO
- Location
- Maryland · United States of America
Registrant
- Firm
- REGENXBIO
- Description
- Gene Therapy Biotechnology Company
- Location
- Rockville, Maryland, United States of America
Lobbying activities
4 issuesTrade (domestic/foreign)
Data protection period for biologic medicines as affected by the proposed USMCA trade agreement.
LobbyistsBRUCE ARTIM
Covered position (BRUCE ARTIM): Senate Judiciary Committee Staff Member 1995-2006; (Chief Counsel and Staff Director 2003-04); Intellectual Property Subcommittee - Chief Counsel and Staff Director 2005-06)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · State, Dept of (DOS) · Patent & Trademark Office (PTO) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS) · Homeland Security, Dept of (DHS)
Copyright/Patent/Trademark
Intellectual Property matters including patent law issues relevant to gene therapy including the issues of subject matter eligibility, the research use exemption, and march in rights. Other issues include legislation affecting so-called "patent thickening" and "product hopping" as they relate to patents protecting gene therapy.
LobbyistsBRUCE ARTIM
Covered position (BRUCE ARTIM): Senate Judiciary Committee Staff Member 1995-2006; (Chief Counsel and Staff Director 2003-04); Intellectual Property Subcommittee - Chief Counsel and Staff Director 2005-06)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · State, Dept of (DOS) · Patent & Trademark Office (PTO) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS) · Homeland Security, Dept of (DHS)